0,845  0,004  Antipsoriatic
0,838  0,012  Apoptosis agonist
0,824  0,012  Antiinflammatory
0,804  0,001  CXC chemokine 3 receptor antagonist
0,763  0,005  Cardiovascular analeptic
0,754  0,009  Antileukemic
0,750  0,008  Respiratory analeptic
0,728  0,017  Antineoplastic (breast cancer)
0,699  0,006  Nitric oxide antagonist
0,700  0,008  Sensitization
0,697  0,008  Bone diseases treatment
0,682  0,005  UDP-glucuronosyltransferase substrate
0,656  0,007  Multiple sclerosis treatment
0,652  0,008  Antiosteoporotic
0,648  0,010  Analeptic
0,643  0,008  Antineoplastic (pancreatic cancer)
0,623  0,003  Antiviral (Influenza A)
0,623  0,009  Immunomodulator
0,613  0,006  UGT1A4 substrate
0,628  0,026  Antineoplastic (lung cancer)
0,586  0,004  Antiacne
0,585  0,004  Antiviral (Influenza)
0,569  0,004  Antialcoholic
0,562  0,018  Immunosuppressant
0,560  0,024  Antiprotozoal
0,548  0,012  Antiprotozoal (Leishmania)
0,532  0,008  Transplant rejection treatment
0,531  0,015  Antineoplastic (multiple myeloma)
0,520  0,010  Vascular (periferal) disease treatment
0,507  0,005  Sepsis treatment
0,506  0,005  Platelet adhesion inhibitor
0,529  0,040  Transcription factor NF kappa B inhibitor
0,517  0,028  Antipruritic, allergic
0,492  0,010  Antineoplastic (liver cancer)
0,508  0,027  Stroke treatment
0,481  0,006  Contraceptive
0,477  0,004  Antieczematic
0,497  0,024  Carcinogenic
0,491  0,025  Antineoplastic (melanoma)
0,476  0,016  Antineoplastic (lymphoma)
0,467  0,014  Angiogenesis stimulant
0,449  0,009  Hair growth stimulant
0,440  0,003  CXC chemokine receptor antagonist
0,461  0,025  Antioxidant
0,442  0,010  Abortion inducer
0,468  0,041  Antineoplastic (colorectal cancer)
0,457  0,033  Antineoplastic (ovarian cancer)
0,454  0,035  Antiprotozoal (Plasmodium)
0,459  0,039  Antineoplastic (colon cancer)
0,460  0,048  CYP3A4 substrate
0,425  0,017  Calcium channel activator
0,416  0,010  Prostate disorders treatment
0,429  0,031  Apoptosis antagonist
0,456  0,059  TNF expression inhibitor
0,469  0,074  Caspase 9 stimulant
0,409  0,019  Antineoplastic enhancer
0,422  0,034  Radioprotector
0,424  0,037  CYP2C19 substrate
0,443  0,059  Antibacterial
0,389  0,005  Antifungal enhancer
0,453  0,071  Antiarthritic
0,412  0,034  Antineoplastic (glioma)
0,401  0,027  Tumour necrosis factor alpha release inhibitor
0,414  0,041  FMO1 substrate
0,383  0,012  Antipruritic, non-allergic
0,386  0,017  Antiparkinsonian, rigidity relieving
0,375  0,011  Pneumotoxic
0,419  0,057  CYP2C9 substrate
0,397  0,040  Spasmolytic
0,367  0,010  UGT2B15 substrate
0,395  0,047  Antifungal
0,348  0,004  Cannabinoid CB2 receptor antagonist
0,368  0,025  Antiulcerative
0,360  0,019  Skin irritative effect
0,339  0,004  Aromatase inhibitor
0,372  0,038  NOS2 expression inhibitor
0,380  0,050  5 Hydroxytryptamine release stimulant
0,379  0,050  Hepatic disorders treatment
0,415  0,088  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,383  0,056  Prostate cancer treatment
0,338  0,017  Diabetic retinopathy treatment
0,327  0,019  Prostatic (benign) hyperplasia treatment
0,323  0,022  UGT2B7 substrate
0,341  0,043  Antihypoxic
0,314  0,018  Interferon gamma antagonist
0,399  0,107  Autoimmune disorders treatment
0,366  0,075  Ulceration
0,336  0,048  UGT2B4 substrate
0,303  0,016  Diabetic nephropathy treatment
0,330  0,044  Antineoplastic (endocrine cancer)
0,295  0,011  UGT2B9 substrate
0,343  0,060  AR expression inhibitor
0,289  0,007  Antispirochetal
0,321  0,041  Antineoplastic (glioblastoma multiforme)
0,333  0,062  Antimycobacterial
0,337  0,068  ICAM1 expression inhibitor
0,272  0,003  Hypercalcemia treatment
0,298  0,030  Hepatoprotectant
0,274  0,009  Chemokine receptor antagonist
0,295  0,032  Antihypotensive
0,312  0,053  Antiprotozoal (Trypanosoma)
0,287  0,031  Non-steroidal antiinflammatory agent
0,279  0,025  Lipocortins synthesis antagonist
0,259  0,008  Contraceptive female
0,292  0,043  Chemopreventive
0,258  0,010  Farnesoid X receptor antagonist
0,265  0,023  Protein kinase stimulant
0,253  0,011  Antismoking
0,291  0,049  5 Hydroxytryptamine uptake stimulant
0,290  0,052  Acute neurologic disorders treatment
0,240  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,290  0,055  Proliferative diseases treatment
0,330  0,097  GABA C receptor rho-3 antagonist
0,325  0,098  GST A substrate
0,257  0,030  Antiviral (Hepatitis)
0,284  0,060  GST M1-1 substrate
0,253  0,030  Antineoplastic (squamous cell carcinoma)
0,253  0,030  Antineoplastic (carcinoma)
0,229  0,006  Actinic keratosis treatment
0,306  0,084  Antithrombotic
0,228  0,012  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,231  0,016  Carcinogenic, group 2B
0,228  0,015  Antirickettsial
0,232  0,019  UGT2B10 substrate
0,257  0,052  Mutagenic
0,263  0,059  DNA synthesis inhibitor
0,251  0,046  VCAM1 expression inhibitor
0,269  0,065  Interleukin agonist
0,244  0,040  CYP2B6 inhibitor
0,230  0,033  Anesthetic
0,205  0,008  Postmenopausal disorders treatment
0,203  0,010  Pregnane X receptor agonist
0,236  0,044  Muscle relaxant
0,213  0,022  Arachidonic acid antagonist
0,252  0,061  Cytotoxic
0,205  0,019  Microtubule formation inhibitor
0,259  0,074  Teratogen
0,216  0,034  Antiviral (Hepatitis C)
0,259  0,077  Chemoprotective
0,197  0,015  Adenylate cyclase stimulant
0,238  0,057  RNA-directed DNA polymerase inhibitor
0,231  0,050  Neurotrophic factor enhancer
0,186  0,006  Anabolic
0,188  0,009  Keratolytic
0,261  0,084  Antituberculosic
0,207  0,034  Bone formation stimulant
0,213  0,041  Cholinergic
0,226  0,057  UGT1A1 substrate
0,172  0,002  Vitamin D receptor antagonist
0,259  0,092  Cardioprotectant
0,236  0,074  Cytostatic
0,173  0,011  Cannabinoid receptor antagonist
0,166  0,009  Paget's disease treatment
0,161  0,005  Oxytocin antagonist
0,238  0,083  Antipyretic
0,232  0,078  Embryotoxic
0,162  0,009  Cannabinoid CB2 receptor agonist
0,186  0,036  Anesthetic local
0,164  0,014  Chymotrypsin inhibitor
0,193  0,043  Skeletal muscle relaxant
0,208  0,059  Sigma receptor agonist
0,250  0,102  FMO3 substrate
0,191  0,043  Uterine stimulant
0,166  0,021  TRPA1 agonist
0,154  0,013  Cannabinoid receptor agonist
0,236  0,095  Transcription factor STAT3 inhibitor
0,219  0,082  Cardiodepressant
0,156  0,021  Androgen antagonist
0,150  0,015  UGT2B11 substrate
0,183  0,049  Melanin inhibitor
0,152  0,020  Acetylcholine nicotinic antagonist
0,133  0,004  Glutamate (mGluR6) antagonist
0,172  0,043  Acetylcholinesterase inhibitor
0,166  0,038  Proteasome inhibitor
0,157  0,029  Ca2+-transporting ATPase inhibitor
0,187  0,060  Succinate dehydrogenase inhibitor
0,135  0,008  Narcotic antagonist
0,144  0,019  ABCA1 expression enhancer
0,136  0,011  Nicotinic alpha4beta2 receptor antagonist
0,189  0,064  LDLR expression enhancer
0,295  0,171  5 Hydroxytryptamine release inhibitor
0,139  0,015  Tocolytic
0,126  0,002  Parathyroid hormone antagonist
0,156  0,033  Vanilloid 1 agonist
0,131  0,008  5-Alpha-reductase inhibitor
0,132  0,011  Na+ K+ transporting ATPase inhibitor
0,244  0,123  Antineoplastic (brain cancer)
0,130  0,012  Hyperparathyroidism treatment
0,137  0,019  Inducible nitric-oxide synthase inhibitor
0,169  0,052  Raynaud's phenomenon treatment
0,193  0,076  Sedative
0,197  0,081  Psychostimulant
0,226  0,111  Gastrin inhibitor
0,131  0,019  Ornithine decarboxylase inhibitor
0,173  0,061  Interleukin 6 antagonist
0,198  0,088  Antiparasitic
0,135  0,025  GST T1-1 substrate
0,159  0,050  Alpha-N-acetylglucosaminidase inhibitor
0,114  0,005  Nicotinic alpha3beta2 receptor antagonist
0,128  0,024  Tourette's syndrome treatment
0,108  0,005  Postcoital contraceptive
0,166  0,063  Acaricide
0,125  0,023  Transcription factor NF kappa B stimulant
0,113  0,011  Androgen agonist
0,206  0,106  Antineoplastic (renal cancer)
0,104  0,005  Anesthetic inhalation
0,152  0,053  Antiseptic
0,109  0,011  Uterine relaxant
0,123  0,025  Antidote, mercury
0,224  0,127  CYP2D6 inhibitor
0,110  0,020  Neuronal nicotinic receptor antagonist
0,093  0,005  Chemokine receptor agonist
0,159  0,072  Eye irritation, high
0,096  0,009  Vasopressin 1 antagonist
0,144  0,058  Carcinogenic, group 3
0,103  0,017  Estrogen agonist
0,113  0,027  Bile acid receptor antagonist
0,132  0,046  Shock treatment
0,206  0,121  Flavin-containing monooxygenase substrate
0,092  0,007  Vasopressin 2 antagonist
0,130  0,045  Choleretic
0,131  0,047  Ferrochelatase inhibitor
0,090  0,006  Vasopressin 1A antagonist
0,084  0,002  Progesterone receptor B antagonist
0,189  0,108  Antineoplastic (cervical cancer)
0,108  0,028  Antiprotozoal activity enhancer
0,087  0,006  Retinoid X alpha receptor agonist
0,169  0,090  Antieczematic atopic
0,149  0,070  Genotoxic
0,106  0,027  Glycine receptor antagonist
0,125  0,046  GABA C receptor agonist
0,083  0,005  Vasopressin 1B antagonist
0,092  0,014  Bombesin 3 receptor antagonist
0,125  0,048  Antiviral (Poxvirus)
0,255  0,178  Analgesic
0,124  0,048  GABA C receptor antagonist
0,205  0,131  Transcription factor STAT inhibitor
0,184  0,111  Free radical scavenger
0,183  0,110  UGT1A6 substrate
0,089  0,016  SULT2A1 substrate
0,104  0,032  Contraceptive male
0,077  0,005  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,079  0,008  Adenylate cyclase 1 inhibitor
0,142  0,072  Antiparkinsonian, tremor relieving
0,151  0,081  Carcinogenic, group 1
0,201  0,133  Tyrosine 3 hydroxylase inhibitor
0,082  0,015  Antidiuretic hormone antagonist
0,124  0,059  Alcohol dehydrogenase substrate
0,157  0,092  Tumour necrosis factor antagonist
0,068  0,004  CYP24 inhibitor
0,127  0,064  Acetylcholine antagonist
0,232  0,170  Histamine release inhibitor
0,128  0,066  Cholinergic antagonist
0,071  0,010  Retinoid X receptor agonist
0,087  0,026  Bcl2 antagonist
0,081  0,022  Acyl-CoA dehydrogenase inhibitor
0,121  0,061  Menstruation disorders treatment
0,117  0,059  SULT1A1 substrate
0,070  0,012  Progesterone antagonist
0,072  0,014  Prolyl endopeptidase inhibitor
0,066  0,010  Liver X receptor alpha agonist
0,075  0,019  Heme oxygenase stimulant
0,137  0,080  SULT1A3 substrate
0,096  0,039  Opioid kappa receptor antagonist
0,086  0,032  Glycine receptor agonist
0,069  0,016  Potassium channel Kv1.3 blocker
0,143  0,089  UGT1A3 substrate
0,087  0,033  Antidote, organophosphates
0,202  0,148  NOS3 expression inhibitor
0,111  0,058  Expectorant
0,105  0,052  Nitric-oxide synthase inhibitor
0,158  0,105  P-glycoprotein inhibitor
0,155  0,104  Antihelmintic
0,056  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,057  0,008  Retinoid X receptor antagonist
0,137  0,088  Diuretic
0,112  0,063  Mucolytic
0,052  0,004  CXC chemokine receptor agonist
0,065  0,017  HCV NS3/NS4A protease inhibitor
0,125  0,078  CNS active muscle relaxant
0,054  0,007  Liver X receptor beta antagonist
0,055  0,009  Glutamate (mGluR8) agonist
0,117  0,071  Beta amyloid protein antagonist
0,190  0,143  UGT1A9 substrate
0,150  0,106  Phospholipase C inhibitor
0,049  0,005  Retinoid X gamma receptor agonist
0,048  0,005  Glutamate (mGluR3) agonist
0,055  0,013  GABA uptake inhibitor
0,172  0,131  5 Hydroxytryptamine 3E antagonist
0,203  0,162  Cholesterol antagonist
0,045  0,005  Progesterone agonist
0,112  0,073  Cholesterol synthesis inhibitor
0,047  0,008  Retinoid X alpha receptor antagonist
0,079  0,042  Vanilloid 4 agonist
0,046  0,010  Tubulin agonist
0,056  0,020  Microtubule stabilization
0,064  0,028  Lipocortins synthesis agonist
0,053  0,018  Glutamate (mGluR group III) antagonist
0,062  0,027  Pregnane X receptor antagonist
0,226  0,192  Rheumatoid arthritis treatment
0,081  0,047  Estrogen receptor alpha antagonist
0,095  0,061  Prolactin inhibitor
0,042  0,008  Liver X receptor alpha antagonist
0,038  0,005  Nicotinic acid receptor 2 antagonist
0,056  0,023  Aldosterone antagonist
0,202  0,170  CTGF expression inhibitor
0,098  0,065  Sulfotransferase substrate
0,060  0,028  Nicotinic receptor alpha7 subunit antagonist
0,037  0,005  Retinoid X gamma receptor antagonist
0,104  0,072  Chelator
0,057  0,026  Purinergic P2X antagonist
0,036  0,005  Retinoic acid gamma receptor agonist
0,060  0,030  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,067  0,037  Cannabinoid CB1 receptor antagonist
0,033  0,004  NMDA receptor phencyclidine site antagonist
0,034  0,007  Retinoid X beta receptor agonist
0,040  0,014  Liver X receptor antagonist
0,031  0,004  Retinoid X beta receptor antagonist
0,046  0,020  Kainate receptor agonist
0,106  0,081  Antiviral (CMV)
0,097  0,072  Adenylate kinase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,101  0,076  Endometrios treatment
0,033  0,009  Retinoic acid receptor agonist
0,075  0,051  Antibiotic
0,147  0,124  Phobic disorders treatment
0,095  0,072  Glutathione S-transferase substrate
0,181  0,159  Antiepileptic
0,079  0,058  Antineoplastic antibiotic
0,027  0,006  Retinoic acid beta receptor agonist
0,043  0,022  Membrane dipeptidase inhibitor
0,040  0,019  Glucocorticoid antagonist
0,110  0,091  Antifungal (Pneumocystis)
0,082  0,063  Antineoplastic alkaloid
0,096  0,077  Antiprotozoal (Toxoplasma)
0,171  0,153  Superoxide dismutase inhibitor
0,068  0,050  Anticholelithogenic
0,044  0,027  Alpha 1L adrenoreceptor agonist
0,041  0,024  Retinoic acid alpha receptor agonist
0,026  0,009  Retinoic acid alpha receptor antagonist
0,044  0,027  Guanylate cyclase inhibitor
0,059  0,042  Ryanodine receptor antagonist
0,061  0,045  Antimycoplasmal
0,022  0,005  Vitamin D receptor agonist
0,059  0,043  Cannabinoid CB1 receptor agonist
0,034  0,019  ATP citrate lysase inhibitor
0,081  0,065  Estrogen-related receptor beta agonist
0,071  0,056  Acetylcholine M4 receptor antagonist
0,018  0,004  Progesterone receptor A antagonist
0,051  0,037  Aconitate hydratase inhibitor
0,140  0,126  Anesthetic general
0,021  0,007  Telomerase stimulant
0,112  0,098  Antimutagenic
0,033  0,019  RNA-directed RNA polymerase stimulant
0,016  0,002  CXC chemokine 3 receptor agonist
0,024  0,010  5-Alpha-reductase 2 inhibitor
0,100  0,087  Acetylcholine release stimulant
0,094  0,082  Excitatory amino acid transporter EAAC1 inhibitor
0,021  0,010  Retinoic acid receptor antagonist
0,088  0,078  Electrolyte absorption antagonist
0,033  0,023  Carboxypeptidase B inhibitor
0,039  0,029  AMPA 4 receptor antagonist
0,037  0,028  Potassium channel Kv1.1 blocker
0,063  0,054  Phosphofructokinase-1 inhibitor
0,083  0,074  Thioredoxin inhibitor
0,076  0,068  Carcinogenic, group 2A
0,053  0,046  Kallikrein 1 inhibitor
0,053  0,046  Glutamate (mGluR1) antagonist
0,067  0,061  Glutamate dehydrogenase inhibitor
0,008  0,002  Vitamin D-like
0,050  0,044  Lysine-specific demethylase 1A inhibitor
0,099  0,094  Antineoplastic antimetabolite
0,091  0,086  UGT2B1 substrate
0,027  0,022  Hedgehog signaling activator
0,080  0,076  Triose-phosphate isomerase inhibitor
0,019  0,016  Antibiotic Quinolone-like
0,018  0,015  Methylmalonyl-CoA mutase inhibitor
0,011  0,009  Retinoic acid receptor gamma antagonist
0,019  0,018  Corticosteroid-like
0,019  0,017  Nociceptin (N/OFQ) receptor agonist
0,015  0,013  5-Alpha-reductase 1 inhibitor
0,106  0,106  Cocaine dependence treatment
0,064  0,063  Epoxide hydrolase inhibitor
0,041  0,040  Heme oxygenase inhibitor
0,011  0,010  Retinoic acid beta receptor antagonist

